Join to View Full Profile
9 Canoe Brook RdShort Hills, NJ 07078
Phone+1 973-376-0437
Dr. Fischkoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 1976 - 1979
Perelman School of Medicine at the University of PennsylvaniaClass of 1976
Certifications & Licensure
NY State Medical License 1977 - Present
PA State Medical License 1985 - 2026
MD State Medical License 1981 - 1986
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis Start of enrollment: 2010 Dec 01
- A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- 6 citationsEffect of bremelanotide on body weight of obese women: Data from two phase 1 randomized controlled trials.Carl Spana, Robert Jordan, Steven Fischkoff
Diabetes, Obesity & Metabolism. 2022-06-01 - 22 citationsSafety and efficacy of intramuscular human placenta-derived mesenchymal stromal-like cells (cenplacel [PDA-002]) in patients who have a diabetic foot ulcer with periph...Stephanie C. Wu, Richard Pollak, Robert G. Frykberg, Wei Zhou, Maha Karnoub
International Wound Journal. 2017-01-30 - 84 citationsHuman placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A randomized, placebo-controlled, multiple-dose study $Fred D. Lublin, James D. Bowen, John Huddlestone, Marcelo Kremenchutzky, Adam F. Carpenter
Multiple Sclerosis and Related Disorders. 2014-11-01
Press Mentions
After Decades of Research, Potential for TILs in Melanoma Is Higher Than EverFebruary 20th, 2016
Up and down the Ladder: The Latest Comings and GoingsFebruary 5th, 2016
Lion Biotechnologies Names Steven A. Fischkoff Chief Medical OfficerFebruary 4th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
